Where is Codexis's headquarters?

Codexis is located in Redwood City, California, United States.

Who invested in Codexis?

Codexis has 7 investors including Innovatus Capital Partners And Innovatus Capital Partners.

When was the last funding round for Codexis?

Codexis closed its last funding round on obfuscated from a Post-IPO Equity round.

Who are Codexis's competitors?

Alternatives and possible competitors to Codexis may include Antheia, Metagenomi, And Resilience.

Codexis - Growth Outlook

Growth Outlook

Growth Score

updated Jun 14, 2026

2 pts

in past quarter

Growth Performance Over Time

Score

Trend

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

Growth Insight

See this Growth Insight

Codexis is

Lorem

to be growing

Top Contributing Factors

Financial Growth

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Companies with Similar Growth

Organization Name	Growth Score	Industries	Headquarters Location	Description
Apogee Therapeutics	89	Biotechnology, Life Science, Medical, Therapeutics	San Francisco, California, United States	Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
Massive Bio	85	Artificial Intelligence (AI), Big Data, Biotechnology, Clinical Trials, Health Care, Machine Learning, Natural Language Processing	Boca Raton, Florida, United States	Massive Bio is building the world's largest global real time cancer registry with patient consented clinical and genomic data.
Nuvalent	87	Biotechnology, Life Science, Therapeutics	Cambridge, Massachusetts, United States	Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.
Isomorphic Labs	91	Artificial Intelligence (AI), Biotechnology, Life Science, Medical	London, England, United Kingdom	Isomorphic Labs is an AI-first drug design and development company that transforms drug discovery to design and evaluate new medicines.
Connecticut Innovations	88	Biotechnology, Business Development, Energy, Information Technology, Media and Entertainment, Venture Capital	Rocky Hill, Connecticut, United States	Connecticut Innovations provides strategic capital and operational insight to to companies in high-tech industries
Humacyte	88	Biotechnology, Medical, Medical Device	Morrisville, North Carolina, United States	Humacyte develops products for vascular diseases and replacement of anatomical conduits.
Neuralink	89	Artificial Intelligence (AI), Biotechnology, Health Care, Medical, Neuroscience, Robotics	Fremont, California, United States	Neuralink is a neurotechnology company that focuses on developing brain-computer interfaces designed to treat neurological disorders.
Indigo	91	Agriculture, AgTech, Carbon Capture, Farming, GreenTech, Sustainability	Boston, Massachusetts, United States	Indigo is an agricultural technology company that focuses on improving sustainability and profitability in farming practices.
Firefly Bio	85	Biotechnology, Life Science, Medical	San Francisco, California, United States	Firefly Bio is a biotechnology company that develops targeted cancer therapeutics based on antibody-drug conjugate (ADC) technology.
BNP Paribas	84	Banking, Consumer Lending, Financial Services, Innovation Management, Sustainability, Wealth Management	Paris, Ile-de-France, France	BNP Paribas is a financial service company that offers commercial, banking, and investment services.